Whitehawk Therapeutics Inc (WHWK) Financials

WHWK Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 194.0 million 11.1 million
March 31, 2026 127.2 million 11.1 million
Dec. 31, 2025 150.8 million 14.5 million
Sept. 30, 2025 167.0 million 9.8 million

WHWK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -14.5 million 1.5 million
March 31, 2026 -22.2 million 2.2 million
Dec. 31, 2025 -17.2 million 2.4 million
Sept. 30, 2025 -15.4 million 2.7 million

WHWK Net Income

No data available :(

WHWK Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 190.0 million - -
March 31, 2026 123.0 million - -
Dec. 31, 2025 145.7 million - -
Sept. 30, 2025 162.6 million - -

WHWK Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 82.9 million
March 31, 2026 69.2 million
Dec. 31, 2025 69.2 million
Sept. 30, 2025 69.2 million

WHWK Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 12.9 million 5.2 million -
March 31, 2026 - 17.2 million 6.3 million -
Dec. 31, 2025 - 19.0 million 5.9 million -
Sept. 30, 2025 - 14.3 million 5.2 million -

WHWK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -
Dec. 31, 2025 - 1000
Sept. 30, 2025 - 5000

WHWK

Price: $4.69

52 week price:
1.57
5.50

Earnings Per Share: -1.21 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 268.5 million

Links: